Exhibit 99.1 CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS As at and for the three and nine months ended September 30, 2025 and 2024 (Unaudited - expressed in U.S. Dollars) XORTX THERAPEUTICS INC. Condensed Interim Consolidated Statements of Financial Position (Unaudited - expressed in U.S. Dollars) | | | September 30, | December 31, | | --- | --- | --- | --- | | | Note | 2025 | 2024 | | | | $|$ | | Assets | | | | | Current | | | | | Cash | 5 | 1,193,915 | 2,473,649 | | Accounts receivable | | 22,09 ...